Characteristic | Odds ratio | 95% CI | p-value |
---|---|---|---|
Age* | 0.97 | 0.9 – 1.02 | 0.20 |
Sex (F vs. M) | 0.8 | 0.3 – 2.6 | 0.71 |
Duration of symptoms prior to RT | |||
≤ 6 months | reference | ||
6 – 18 months | 0.79 | 0.3 – 2.5 | 0.69 |
> 18 months | 1.08 | 0.3 – 4.2 | 0.92 |
Total score at diagnosis | |||
(≥ 6 vs. < 6) | 2.71 | 0.9 – 7.9 | 0.07 |
Disease severity | |||
Mild | reference | ||
Moderate | 2.78 | 0.7 – 10.6 | 0.14 |
Severe | 3.33 | 0.4 – 25.4 | 0.25 |
Prior surgery | 3.89 | 0.2 – 65.2 | 0.35 |
Prior steroid use | 1.24 | 0.5 – 3.4 | 0.68 |
Response to prior steroids | |||
(PR vs. none) | 0.84 | 0.2 – 4 0 | 83 |
Steroids at initiation of RT | 1.17 | 0.4 – 3.3 | 0.77 |
Current smoking | 3.6 | 1.3 – 10.3 | 0.02# |
Total score at 1 month | |||
(> 4 vs. ≤ 4) | 3.03 | 1.04 – 8.9 | 0.04# |
Total score at 4 months* | 1.65 | 1.2 – 2.3 | 0.003# |
Symptoms at diagnosis: | |||
Soft tissue | 0.63 | 0.2 – 1.7 | 0.37 |
Proptosis | 1.15 | 0.4 – 3.6 | 0.81 |
EOM dysfunction | 0.62 | 0.2 – 1.7 | 0.35 |
Objective vision loss | 1.59 | 0.6 – 4.4 | 0.37 |
Diplopia | 2.63 | 0.6 – 12.5 | 0.23 |
Symptoms at 4 months: | |||
Soft tissue | 1.22 | 0.4 – 3.5 | 0.70 |
Proptosis | 2.12 | 0.6 – 7.1 | 0.22 |
EOM dysfunction | 2 | 0.7 – 5.7 | 0.19 |
Objective vision loss | 4.45 | 1.5 – 12.9 | 0.01# |
Diplopia | 1.03 | 0.4 – 2.9 | 0.96 |